H.R. 530

119th Congress

In Committee

ACES Act

Sponsored byRepublican:Rep. Pfluger, August [R-TX-11]TX· Introduced 16 January 2025

35

Cosponsors

17

Actions

0

Amendments

2

Committees

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

6 May 2025·1 year ago

Summary

Introduced in House · Updated 3 March 2025

ACES Act

This bill requires the Department of Veterans Affairs to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to study and report on the prevalence and mortality of cancers among veterans who served on active duty as aircrew members and regularly flew in fixed-wing aircraft.

 

Timeline

17 actions

  1. Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

    6 May 2025 · IntroReferral

  2. On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 376 - 5 (Roll no. 115). (text: CR H1815)

    5 May 2025 · Floor

  3. Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 376 - 5 (Roll no. 115). (text: CR H1815: 6)

    5 May 2025 · Floor

  4. DEBATE - The House proceeded with forty minutes of debate on H.R. 530.

    5 May 2025 · Floor

  5. Mr. Bergman moved to suspend the rules and pass the bill, as amended.

    5 May 2025 · Floor

  6. Considered as unfinished business. (consideration: CR H1839-1840)

    5 May 2025 · Floor

  7. At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

    5 May 2025 · Floor

  8. Considered under suspension of the rules. (consideration: CR H1815-1817)

    5 May 2025 · Floor

  9. Motion to reconsider laid on the table Agreed to without objection.

    5 May 2025 · Floor

  10. Forwarded by Subcommittee to Full Committee by Voice Vote.

    9 April 2025 · Committee

  11. Subcommittee Consideration and Mark-up Session Held

    9 April 2025 · Committee

  12. Referred to the Subcommittee on Disability Assistance and Memorial Affairs.

    26 March 2025 · Committee

  13. Subcommittee Hearings Held

    26 March 2025 · Committee

  14. Referred to the Subcommittee on Health.

    20 February 2025 · Committee

  15. Referred to the House Committee on Veterans' Affairs.

    16 January 2025 · IntroReferral

  16. Introduced in House

    16 January 2025 · IntroReferral

  17. Introduced in House

    16 January 2025 · IntroReferral

Sponsorship

35 cosponsors

Sponsor

Republican:Rep. Pfluger, August [R-TX-11]TX

Cosponsors

  • Democrat1646%
  • Republican1954%

Classification

Policy area

Armed Forces and National Security

Legislative subjects

Aviation and airportsCancerCongressional oversightGovernment studies and investigationsHazardous wastes and toxic substancesMedical researchResearch administration and fundingVeterans' medical care

Committees

2

  • Veterans' Affairs Committee

    House · Standing

    • Referred To16 Jan 2025
    • Disability Assistance and Memorial Affairs Subcommittee

      • Referred to26 Mar 2025
      • Hearings By (subcommittee)26 Mar 2025
      • Markup by9 Apr 2025
      • Reported by9 Apr 2025
    • Health Subcommittee

      • Referred to20 Feb 2025
  • Veterans' Affairs Committee

    Senate · Standing

    • Referred To6 May 2025

Cosponsor momentum

Cumulative over time

Cosponsors grew from 13 on 16 January 2025 to 35 on 26 September 2025.

Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.